Literature DB >> 9397222

References for health-related quality-of-life claims in prescription drug advertisements.

E A Rothermich1, D S Pathak.   

Abstract

Mesh：

Year:  1997        PMID： 9397222     DOI： 10.1093/ajhp/54.22.2596

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN： 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  4 in total

1.  A new index of priority symptoms in advanced ovarian cancer.

Authors:  Sally E Jensen; Sarah K Rosenbloom; Jennifer L Beaumont; Amy Abernethy; Paul B Jacobsen; Karen Syrjala; David Cella
Journal:  Gynecol Oncol       Date:  2010-11-13       Impact factor: 5.482

2.  Development and validation of 11 symptom indexes to evaluate response to chemotherapy for advanced cancer.

Authors:  David Cella; Sarah K Rosenbloom; Jennifer L Beaumont; Susan E Yount; Diane Paul; Debra Hampton; Amy P Abernethy; Paul B Jacobsen; Karen Syrjala; Jamie H Von Roenn
Journal:  J Natl Compr Canc Netw       Date:  2011-03       Impact factor: 11.908

Review 3.  Quality of pharmaceutical advertisements in medical journals: a systematic review.

Authors:  Noordin Othman; Agnes Vitry; Elizabeth E Roughead
Journal:  PLoS One       Date:  2009-07-22       Impact factor: 3.240

4.  Brief assessment of priority symptoms in hormone refractory prostate cancer: the FACT Advanced Prostate Symptom Index (FAPSI).

Authors:  Susan Yount; David Cella; Donald Banik; Talat Ashraf; Daniel Shevrin
Journal:  Health Qual Life Outcomes       Date:  2003-11-21       Impact factor: 3.186
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.